Systemically Expressed Soluble Tie2 Inhibits Intraocular Neovascularization

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Human Gene Therapy

• Publication date

  2001-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/104303401750270968PMID 11440624
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gene therapy for retinal and choroidal diseases

  2002cited by this paper
• Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization.

  2000cited by this paper
• Experimental subretinal neovascularization is inhibited by adenovirus-mediated soluble VEGF/flt-1 receptor gene transfection: a role of VEGF and possible treatment for SRN in age-related macular degeneration

  2000cited by this paper
• Increased levels of platelet-derived growth factor in vitreous fluid of patients with proliferative diabetic retinopathy.

  2000cited by this paper
• Natural history of choroidal neovascularization induced by vascular endothelial growth factor in the primate

  2000cited by this paper
• Angiopoietin-1 protects the adult vasculature against plasma leakage

  2000cited by this paper
• Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization.

  2000cited by this paper
• Peroxisome Proliferator-Activated Receptor-γ Ligands Inhibit Choroidal Neovascularization

  2000cited by this paper
• Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy

  2000cited by this paper
• VEGF is major stimulator in model of choroidal neovascularization.

  2000cited by this paper
• Clinical applications of angiogenic growth factors and their inhibitors

  1999cited by this paper
• Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor.

  1999influential reference
• Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes.

  1999cited by this paper
• Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention.

  1999cited by this paper
• Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

  1999cited by this paper
• Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1.

  1999cited by this paper
• Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation.

  1999cited by this paper
• Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor

  1999cited by this paper
• Vascular Endothelial Growth Factor Has Neurotrophic Activity and Stimulates Axonal Outgrowth, Enhancing Cell Survival and Schwann Cell Proliferation in the Peripheral Nervous System

  1999cited by this paper
• The pathogenesis of choroidal neovascularization in patients with age-related macular degeneration.

  1999cited by this paper
• Ocular neovascularization: clarifying complex interactions.

  1998cited by this paper
• Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization.

  1998influential reference
• Time-course expression of vascular endothelial growth factor as related to the development of the retinochoroidal vasculature in rats

  1998cited by this paper
• Angiopoietin-1 induces sprouting angiogenesis in vitro.

  1998cited by this paper
• Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2.

  1998influential reference
• Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model.

  1998cited by this paper
• Ocular neovascularization: an epidemiologic review.

  1998cited by this paper
• Vitrectomy for diabetic macular edema associated with a taut premacular posterior hyaloid.

  1998cited by this paper
• Hepatocyte Growth Factor in Vitreous Fluid of Patients With Proliferative Diabetic Retinopathy and Other Retinal Disorders

  1998cited by this paper
• Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues.

  1997influential reference
• Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.

  1997influential reference
• Vascular endothelial growth factor. 20th-century mechanisms, 21st-century therapies.

  1997cited by this paper
• Signaling Vascular Morphogenesis and Maintenance

  1997cited by this paper
• Expression of vascular endothelial growth factor in experimental choroidal neovascularization

  1997cited by this paper
• Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy.

  1997cited by this paper
• Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning.

  1996cited by this paper
• Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis.

  1996cited by this paper
• Role of integrins in angiogenesis.

  1996cited by this paper
• Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2.

  1996cited by this paper
• Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes.

  1996cited by this paper
• Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy.

  1996cited by this paper
• Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor.

  1996cited by this paper
• Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.

  1995cited by this paper
• Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation

  1995cited by this paper
• Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.

  1995cited by this paper
• Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy

  1995cited by this paper
• Mechanisms of retinal and choroidal neovascularization.

  1994cited by this paper
• Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy.

  1994cited by this paper
• Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

  1994cited by this paper
• Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model.

  1994cited by this paper
• Growth factor localization in choroidal neovascular membranes of age-related macular degeneration.

  1994cited by this paper
• Oxygen-induced retinopathy in the mouse.

  1994cited by this paper
• Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.

  1993cited by this paper
• Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system.

  1993cited by this paper
• Inhibition of angiogenesis.

  1992cited by this paper
• Insulin-Like Growth Factors in Vitreous: Studies in Control and Diabetic Subjects with Neovascularization

  1986cited by this paper

• Faricimab for neovascular age-related macular degeneration and diabetic macular edema: from preclinical studies to phase 3 outcomes

  2024cites this paper
• Insights to Ang/Tie signaling pathway: another rosy dawn for treating retinal and choroidal vascular diseases

  2024cites this paper
• Beyond VEGF: Angiopoietin–Tie Signaling Pathway in Diabetic Retinopathy

  2024cites this paper
• Essential Contribution of Macrophage Tie2 Signalling in a Murine Model of Laser-Induced Choroidal Neovascularization

  2020cites this paper
• Soluble Tei2 fusion protein inhibits retinopathy of prematurity occurrence via regulation of the Ang/Tie2 pathway

  2019cites this paper
• Targeting the Tie2–αvβ3 integrin axis with bi-specific reagents for the inhibition of angiogenesis

  2018cites this paper
• miR144‐3p inhibits PMVECs excessive proliferation in angiogenesis of hepatopulmonary syndrome via Tie2

  2018cites this paper
• Inhibitory Effects On Retinal Neovascularization by Ranibizumab and sTie2-Fc in An Oxygen-Induced Retinopathy Mouse Model

  2018cites this paper
• Utilizing combinatorial engineering to develop Tie2 targeting antagonistic angiopoetin-2 ligands as candidates for anti-angiogenesis therapy

  2017cites this paper
• Microvascular complications and diabetic retinopathy: recent advances and future implications.

  2013cites this paper
• The isolation, characterisation and investigation into the in vitro behaviour of human ocular vascular endothelial cells

  2013cites this paper
• Regulation of Angiogenesis and Vascular Homeostasis Through the Angiopoietin / Tie System

  2012cites this paper
• Pharmacotherapy of Age-Related Macular Degeneration

  2012cites this paper
• A novel angiopoietin‐derived peptide displays anti‐angiogenic activity and inhibits tumour‐induced and retinal neovascularization

  2012cites this paper
• AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, inhibits angiogenesis in models of ocular neovascular diseases.

  2012cites this paper
• Lack of Efficacy of Combined Antiangiogenic Therapies in Xenografted Human Melanoma

  2011cites this paper
• Microvascular Modifications in Diabetic Retinopathy

  2011cites this paper
• Angiogenic Gene Therapy for the Treatment of Retinopathies

  2010cites this paper
• Untersuchung zur transkriptionellen Regulation des Angiopoietin-2 in humanen Endothelzellen

  2010cites this paper
• The angiopoietin/Tie2 axis mediates malignant pleural effusion formation.

  2009cites this paper
• Mediators of ocular angiogenesis

  2009cites this paper
• Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: Soluble Tie-2

  2008cites this paper
• Anti-VEGF and Other Pharmacologic Treatments for Age-Related Macular Degeneration

  2008cites this paper
• EPH RECEPTOR TYROSINE KINASES: MODULATORS OF ANGIOGENESIS

  2008cites this paper
• Relationship to retinopathy of prematurity

  2008cites this paper
• Long-term genetic modification of the ocular outflow tract and the retinal pigment epithelium with feline immunodeficiency viral vectors

  2008cites this paper
• Inhibition of in vivo tumor angiogenesis and growth via systemic delivery of an angiopoietin 2-specific RNA aptamer.

  2008cites this paper
• VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants: relationship to retinopathy of prematurity

  2008cites this paper
• Angiopoietins and Tie Receptors

  2008cites this paper
• Inhibitio no fI nViv oTumo rAngiogenesi san dGrowt hVi aSystemic Deliver yo fa nAngiopoieti n2-Specifi cRN AAptamer

  2008cites this paper
• Regulation of endothelial cell cytoskeletal reorganization by a secreted frizzled-related protein-1 and frizzled 4- and frizzled 7-dependent pathway: role in neovessel formation.

  2008cites this paper
• Growth Factors and Neurotrophic Factors as Targets

  2008cites this paper
• Angiogenic Factors and Inhibitors

  2008cites this paper
• Identification and characterization of small‐molecule inhibitors of Tie2 kinase

  2008cites this paper
• Gene therapy in type 1 diabetes.

  2008cites this paper
• Beyond VEGF – Other Factors Important in Retinal Neovascularization: Potential Targets in Proliferative Diabetic Retinopathy

  2008cites this paper
• Angiopoietin-2 Antagonists for Anti-Angiogenic Therapy

  2008cites this paper
• ROLE OF SHEAR STRESS IN ANGIOPOIETIN-2-DEPENDENT NEOVASCULARIZATION: IMPLICATIONS IN OCCLUSIVE VASCULAR DISEASE AND ATHEROSCLEROSIS

  2008cites this paper
• Molecular targets for retinal vascular diseases

  2007cites this paper
• Angiopoietin: A TIE(d) Balance in Tumor Angiogenesis

  2007cites this paper
• Gene therapy for ocular neovascularization.

  2007cites this paper
• Receptor tyrosine kinase inhibitors AG013764 and AG013711 reduce choroidal neovascularization in rat eye.

  2007influential citation
• Gene Therapy Targeted at Angiogenesis and Lymphangiogenesis for Cancer Treatment

  2007cites this paper
• Molecular biology of choroidal neovascularization.

  2006cites this paper
• Ocular angiogenesis: the role of growth factors.

  2006cites this paper
• Chapter 65 – Pharmacotherapy of Age-Related Macular Degeneration

  2006cites this paper
• Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling.

  2006cites this paper
• A comparison of antiangiogenic therapies for the prevention of liver metastases.

  2006cites this paper
• Anti-VEGF Therapies for Diseases of the Retina and Choroid

  2006cites this paper
• Abnormal angiopoietins 1&2, angiopoietin receptor Tie‐2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub‐study of the Anglo‐Scandinavian Cardiac Outcomes Trial (ASCOT)]

  2005cites this paper
• Neutrophils promote experimental choroidal neovascularization.

  2005cites this paper
• Gene therapy targeting the Tie2 function ameliorates collagen-induced arthritis and protects against bone destruction.

  2005cites this paper
• Hepatic Tumor Growth: Target for Angiogenesis Inhibition?

  2005cites this paper
• Systemic soluble Tie2 expression inhibits and regresses corneal neovascularization.

  2005cites this paper
• Complete inhibition of goiter in mice requires combined gene therapy modification of angiopoietin, vascular endothelial growth factor, and fibroblast growth factor signaling.

  2005cites this paper
• Stable interaction between (cid:1) 5 (cid:2) 1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1

  2005cites this paper
• Stable interaction between α5β1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1

  2005cites this paper
• Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration.

  2005cites this paper
• Vasoactive factors and diabetic retinopathy: vascular endothelial growth factor, cycoloxygenase-2 and nitric oxide.

  2004cites this paper
• Current concepts in the pathogenesis of age-related macular degeneration.

  2004cites this paper
• Functional significance of Tie2 signaling in the adult vasculature.

  2004cites this paper
• Ocular neovascularisation and excessive vascular permeability

  2004influential citation
• Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2.

  2004cites this paper
• CAI is a potent inhibitor of neovascularization and imparts neuroprotection in a mouse model of ischemic retinopathy.

  2004cites this paper
• Periocular Gene Transfer of sFlt-1 Suppresses Ocular Neovascularization and Vascular Endothelial Growth Factor-Induced Breakdown of the Blood-Retinal Barrier

  2003cites this paper
• Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies.

  2003cites this paper
• Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors.

  2003cites this paper
• Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin.

  2003cites this paper
• Gene therapy for ocular neovascularization: a cure in sight.

  2003cites this paper
• Retinal and choroidal angiogenesis: pathophysiology and strategies for inhibition.

  2003cites this paper
• Ocular neovascularization: a valuable model system

  2003influential citation
• Tie2 receptor tyrosine kinase, a major mediator of tumor necrosis factor alpha-induced angiogenesis in rheumatoid arthritis.

  2003cites this paper
• Angiopoietin/Tek Interactions Regulate MMP-9 Expression and Retinal Neovascularization

  2003cites this paper
• Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization.

  2003cites this paper
• Reduced choroidal neovascular membrane formation in matrix metalloproteinase-2-deficient mice.

  2003cites this paper
• Pharmacological regulation of protein expression from adeno-associated viral vectors in the eye.

  2002cites this paper
• Gene therapy for retinal and choroidal diseases

  2002cites this paper
• Theoretical Biology and Medical Modelling

  year unknowncites this paper